期刊文献+

温阳利水法对慢性肾心综合征患者中医证候及心肾功能的影响

Effect of Wenyang Lishui Method on TCM Syndrome,Cardiac and Renal Function in Patients with Chronic Renal Heart Syndrome
原文传递
导出
摘要 目的探究温阳利水法对慢性肾心综合征患者中医证候及心肾功能的影响.方法选择本院2021年3月—2022年5月收治的共86例慢性肾心综合征患者,按随机数字表法分为对照组、观察组,每组43例.对照组采用常规治疗,观察组在此基础上采用温阳利水法治疗,均持续治疗2个月.比较两组患者的中医证候、心功能、肾功能及安全性.结果观察组治疗后的胸闷、气短、面肢浮肿、畏寒肢冷、疲倦乏力评分分别为(1.52±0.16)分、(1.41±0.13)分、(1.33±0.15)分、(0.71±0.10)分、(0.78±0.09)分,均低于对照组,组间差异有统计学意义(P<0.05).观察组治疗后的左心室收缩末期内径、左心室舒张末期内径分别为(30.05±1.26)mm、(42.28±1.49)mm,均低于对照组,左室射血分数为(49.93±3.15)%,高于对照组,组间差异有统计学意义(P<0.05).观察组治疗后的尿素氮、血肌酐、胱抑素C水平分别为(6.53±1.02)mmol/L、(143.37±13.50)μmol/L、(0.86±0.17)mg/L,均低于对照组,组间差异有统计学意义(P<0.05).两组均未发生明显不良反应.结论采用温阳利水法治疗慢性肾心综合征患者,可有效减轻其临床症状,改善心肾功能,且安全可靠,值得临床推广使用. Objective To explore the effect of Wenyang Lishui method on TCM syndrome,cardiac and renal function in patients with chronic renal heart syndrome.Methods 86 patients with chronic renal heart syndrome admitted to our hospital from March 2021 to May 2022 were selected and were divided into a control group and an observation group according to random number table method,with 43 cases in each group.The control group was treated with conventional treatment,while the observation group was treated with Wenyang Lishui method.Both groups were treated for 2 months.The TCM syndrome,cardiac function,renal function and safety between the two groups were compared.Results After treatment,the scores of chest tightness,shortness of breath,facial edema,cold fear and fatigue in the observation group were(1.52±0.16)points,(1.41±0.13)points,(1.33±0.15)points,(0.71±0.10)points and(0.78±0.09)points,respectively,which were lower than those in the control group,the differences between the groups were statistically significant(P<0.05).The left ventricular end-systolic diameter and left ventricular end-diastolic diameter of the observation group after treatment were(30.05±1.26)mm and(42.28±1.49)mm,respectively,lower than those of the control group,the left ventricular ejection fraction was(49.93±3.15)%,higher than that of the control group,and the differences between the groups were statistically significant(P<0.05).After treatment,the levels of urea nitrogen,blood creatinine and cystatin C in the observation group were(6.53±1.02)mmol/L,(143.37±13.50)μmol/L and(0.86±0.17)mg/L,respectively,which were lower than those in the control group,and the differences between the groups were statistically significant(P<0.05).No obvious adverse reactions occurred in the two groups.Conclusion The treatment of chronic renal heart syndrome by Wenyang Lishui method can effectively reduce clinical symptoms,improve cardiac and renal function,and is safe and reliable,worthy of clinical application.
作者 李铭新 任海艇 张建民 LI Mingxin;REN Haiting;ZHANG Jianmin(Department of Heart Disease,Guangrao Hospital of Traditional Chinese Medicine,Dongying Shandong,257300,China)
出处 《反射疗法与康复医学》 2023年第2期5-7,26,共4页 Reflexology And Rehabilitation Medicine
基金 2020年度山东省中医药科技项目(2020Q089)。
关键词 慢性肾心综合征 温阳利水法 中医证候 心功能 肾功能 Chronic renal heart syndrome Wenyang Lishui method TCM syndromes Cardiac function Renal function
  • 相关文献

参考文献9

二级参考文献139

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3752

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部